Aktis Oncology Logo

Aktis Oncology

🇺🇸
AKTS
US01021M1045

Aktis Oncology is a US-based biotechnology company specializing in the development of innovative radiopharmaceuticals. By leveraging targeted alpha therapies, Aktis Oncology combats cancer with precision and transforms modern oncology to provide improved care and outcomes for patients worldwide.

Next Quarterly Earnings

Monday, March 29, 2027
Expected

Stock Price

Frequently asked questions

When did Aktis Oncology last report quarterly earnings?

Aktis Oncology last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at -0.44 USD.

How do I add the Aktis Oncology earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Missed
Estimate:-$0.43
Actual:-$0.44
Difference:-$0.01
Q1 2026
Missed
Estimate:-$0.36
Actual:-$0.38
Difference:-$0.02
Price reaction (1 day):+8.0 %
Price reaction (7 days):+1.9 %

Company Information

Name
Aktis Oncology
Ticker Symbol
AKTS
ISIN
US01021M1045
Country
🇺🇸
USA
Sector
More Financial Information